← Leaderboards
Anne W Hamburger
University Of Maryland Baltimore
$3,712,195
Attributed
$3,712,195
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $467.8K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,712,195 · 4
By mechanism
R01$2,559,107 · 2
RC1$930,338 · 1
R21$222,750 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Angela M. Brodie$7,232,468
- Amy Fulton$3,639,782
- Vincent Collins Ofuka Njar$7,431,601
- Carl P Weiner$4,352,392
- Richard J Traub$7,380,364
Others in their field
Top investigators on “Phosphorylation”
- Paul S. Aisen · Cognition Therapeutics, Inc.$88,828,963
- Alan F Horwitz · University Of Virginia Charlottesville$38,916,638
- Tony R. Hunter · Salk Institute For Biological Studies$34,955,666
- Adam L Boxer · Mayo Clinic Rochester$31,930,809
- Keith A. Johnson · Banner Health$30,350,302
- Paul Greengard · Rockefeller University$28,632,392
Research focus
PhosphorylationCell LineGene TargetingBinding ProteinsGenetic Promoter ElementGenetic TranscriptionGrowth Factor ReceptorsLaboratoriesBaseInhibitor/AntagonistAndrogen ReceptorIn VitroCell GrowthHormonesCell Growth RegulationAnimal ModelBreast NeoplasmsHeregulinDesignEventImmunologic Substance Development /PreparationGene Induction /RepressionBinding (Molecular Function)In Vivo
Grant awards (13)
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC$263,318
R01 · FY2013 · CA · contact PI
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC$280,125
R01 · FY2012 · CA · contact PI
A Novel Mechanism for Control of Androgen Receptor Levels in HRPC$280,125
R01 · FY2011 · CA · contact PI
A novel therapy for HER2 positive hormone refractory breast cancer$462,585
RC1 · FY2010 · CA · contact PI
A novel therapy for HER2 positive hormone refractory breast cancer$467,753
RC1 · FY2009 · CA · contact PI
ErbB Receptor Control of Breast Cancer Growth$258,118
R01 · FY2006 · CA · contact PI
ErbB Receptor Control of Breast Cancer Growth$234,539
R01 · FY2005 · CA
ErbB Receptor Control of Breast Cancer Growth$373,100
R01 · FY2004 · CA
ErbB Receptor Control of Breast Cancer Growth$371,265
R01 · FY2003 · CA
ErbB Receptor Control of Breast Cancer Growth$264,330
R01 · FY2002 · CA
EBP1 CONTROL OF PROSTATE CANCER CELL GROWTH$111,375
R21 · FY2002 · CA
EBP1 CONTROL OF PROSTATE CANCER CELL GROWTH$111,375
R21 · FY2001 · CA
ERBB RECEPTOR CONTROL OF BREAST CANCER GROWTH$234,187
R01 · FY2000 · CA